Our Goals

We would like to see the government take the following steps:

  1. Inform and engage Canadians on the needs and benefits of mass rapid testing and tracing for COVID-19
  2. Launch pilot studies using mass rapid testing across Canada in preparation for a national rollout
  3. Create a federal task force to develop a national plan for mass rapid testing
  4. Quickly increase daily rapid testing across Canada: starting with 200,000 rapid tests/day by February, to 5 million rapid tests/day by April 2021
  5. Develop an information hub and reference site for COVID-19 information and prevention

Who We Are

We are a coalition of academics, public health professionals, and medical specialists, in partnership with businesses in the health, hospitality, and cultural sectors and other concerned citizens.

Sandy White

Sandy White

Co-Founder

Sandy is an entrepreneur in the real estate and hotel sectors, writer, and former political advisor. He is on the board of a rural hospital in Quebec and was formerly an advisor to the federal Conservative government. He is eager to protect Canadians and to safely reopen our society.

Adam Singfield

Adam Singfield

Co-Founder

Adam is a marketing communications consultant with a background in stakeholder relations and public engagement. His work with small-medium businesses impacted by the pandemic has motivated him to take action. He aims to raise awareness about strategic rapid testing and how it could benefit Canada.

Caroline Colijin

Dr. Caroline Colijn

Professor, Simon Fraser University

Caroline’s work is at the interface of mathematics and the epidemiology and evolution of pathogens. She holds a Canada 150 Research Chair in Mathematics for Evolution, Infection and Public Health. 

Dr. David Juncker

Professor, McGill University

David is Professor and Chair of Biomedical Engineering in the Faculty of Medicine at McGill University. His interests are in micro- and nanobioengineering. including diagnostic technologies, biomarkers, microscopy and mini-artificial organs.

Michael Mina

Dr. Michael Mina

Assistant Professor, Harvard

Michael Mina, MD, PhD, is an assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health and a core member of the School’s Center for Communicable Disease Dynamics (CCDD). He is additionally an assistant professor in immunology and infectious diseases at the Harvard Chan School and associate medical director in clinical microbiology (molecular diagnostics) in the Department of Pathology at Brigham and Women’s Hospital, Harvard Medical School.

Toby Lyle

Toby Lyle

Co-Founder

Toby is the co-founder and operator of a large restaurant group in Montreal. He has always been a vocal advocate for his industry and the rights of its’ workers. He has watched the mismanagement of the pandemic wreak havoc on the lives and welfare of his colleagues and friends. He is committed to promoting intelligent and scientific solutions that will allow our economy to open fully and safely.

David Redman

David Redman

Retired

David Redman is the former executive director of the Alberta Emergency Management Agency. He also served as an officer for 27 years in the Canadian Armed Forces and spent nearly 10 years as an organizational consultant working on best practices for emergency management.

Dr. Victor Leung

Dr. Victor Leung

Professor, University of British Columbia

Victor is the Medical Director for Infection Prevention and Control at Providence Health Care. He is also the Medical Lead for
the PHC Antimicrobial Stewardship Program. He has been practicing clinical infectious diseases and medical microbiology at St. Paul’s
Hospital since completing his fellowships in Infectious Diseases and Medical Microbiology at McGill University.

Dr. Jo Kennelly

Dr. Jo Kennelly

Board Chair & Founder Malaika Vx, HIV vaccine company based on natural immunity to HIV

Dr. Jo Kennelly is the Board Chair and Founder of Malaika Vx – HIV Vaccine company, based on natural immunity to HIV. Other career accomplishments include:

  • Collaborator with Dr. Frank Plummer (OC, OM) on development of  Level 5 Lab plan –  infection control capabilities commensurate with lab capacities during a pandemic and/or bioterrorism outbreak
  • Director of Policy, Federal Health Minister
  • Senior Policy Adviser, Prime Minister of New Zealand (DPMC)
  • Fellowships in health economics: Imperial College London (St Mary’s Hospital),  University College. London (Royal Free Hospital), Centre for Health Economics, University of York, UK
  • Ph.D. (Cambridge), HIV
Stephane Bilodeau

Stéphane Bilodeau

University of Sherbrooke

Stephane Bilodeau, ing., PhD, FEC, is an entrepreneur that founded 2 Cleantech companies and has worked for more than 20 years in the development and deployment of technologies notably associated with Renewables and Energy storage as well as with Data Science, Experimental Methods & Artificial Intelligence. He has been lecturer and Associate professor at the University of Sherbrooke for more than 17 years and is an expert contributor for TowardsDataScience and EnergyCentral. He is a certified Contact Tracer from Johns Hopkins Bloomberg School of Public Health. He has found STIM-COVID and is involved with Endcoronavirus.org, notably as the Team Lead for the Canada Outreach group and as the coordinator of the High-Risk-Institutions advocacy group.

Colin D. Furness

Assistant Professor, Teaching Stream, University of Toronto

Assistant Professor, Teaching Stream, at the University of Toronto, Faculty of Information. His research interests include:

  • effectiveness of information systems for knowledge work
  • information and knowledge management;
  • health behaviour change
  • infection control epidemiology
  • COVID-19 pandemic management in Canada
Prabhat Jha

Dr. Prabhat Jha

Faculty Member, University of Toronto

Prabhat is a Faculty Member at the University of Toronto. His research interests include:

  • Large scale epidemiology studies of the major causes of death in developing countries (tobacco, alcohol, blood pressure, blood cholesterol, indoor air pollution, fertility)
  • Methods of epidemiological research in low-resource settings, including randomized intervention studies
  • Use of routine mortality data for analytic epidemiology
  • Tobacco control policy in developed and developing countries
Ashleigh Tuite

Ashleigh Tuite

Faculty Member, University of Toronto

Ashleigh Tuite is an infectious disease epidemiologist and mathematical modeler. Dr. Tuite’s research program focuses on the use of mathematical modeling and other quantitative methods to improve decision-making for emerging, re-emerging, and endemic communicable diseases. She uses models to project the spread of communicable diseases and better understand and quantify the health, economic, and social implications of different control measures and policies. She is particularly interested in the use of mathematical models to synthesize and communicate complex information and uncertainty.

Dr. Jack Mintz

President's Fellow, The School of Public Policy, University of Calgary

Dr. Jack M. Mintz is the President’s Fellow of the School of Public Policy at the University of Calgary after serving as the Palmer Chair and founding Director from January 1, 2008 to June 30, 2015.

He also serves on the board of Imperial Oil Limited and is the National Policy Advisor for Ernst & Young. He has also become a Distinguished Senior Fellow, MacDonald-Laurier Institute, Senior Fellow at the C.D. Howe Institute and a director of the Canada West Foundation. He is also a regulator contributor to the Financial Post and is a member of the editorial board of International Tax and Public Finance.

Marc Levine

Marc Levine, Ph.D.

Professor Emeritus, Faculty of Pharmaceutical Sciences, University of British Columbia

Dr. Levine is a Professor Emeritus from the Faculty of Pharmaceutical Sciences, The University of British Columbia. Marc’s teaching and research have included therapeutics, clinical pharmacology, and methods for the design and analysis of clinical and biomedical research. The latter included the basis for diagnostic and screening tests and their application to research and clinical practice. He has recently spoken on COVID-19 vaccine development and is advocating the potential of rapid antigen testing to more safely open society and the economy. Marc currently serves as Chair of the University of British Columbia Children’s & Women’s Research Ethics Board (UBC C&W REB).

Danny Bianco

Danny Bianco

Translator

Danny is our translator and a manager in the Burgundy Lion group. He has been part of the restaurant industry for over 15 years and has seen firsthand the repercussions of the mismanagement of Covid-19. He hopes to be able to get involved in the adoption of new measures for the safe reopening of restaurants and other affected industries.

Contribute Your Expertise

Would you like to get involved with Test & Trace Canada? Please get in touch and let us know how you would like to support the movement to implement rapid testing in Canada. 

Proudly trusted by hundreds of organizations across Canada

Stay up to date with Rapid Test & Trace Canada

Scroll to Top